This paper reviews the organisation and outcomes of a pleural service, specifically geared towards the management of malignant pleural effusions, in a district general hospital in the north east of England. We summarise the evidence behind local anaesthetic thoracoscopy and indwelling pleural catheters. We then summarise the review of our service, including a discussion around complications.
Rodriguez-PanaderoF, BorderasNF. Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J1989; 2: 366–9.
4.
RobertsME, NevilleE, BerrisfordRG. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax2010; 65: ii32–ii40. http://dx.doi.org/10.1136/thx.2010.136994
5.
CliveAO, KahanBC, HooperCE. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax2014; 69: 1098–1104. http://dx.doi.org/10.1136/thoraxjnl-2014-205285
6.
HopperC, LeeYCG, MaskellN. Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010. Thorax2010; 65: ii4–ii17. http://dx.doi.org/10.1136/thx.2010.136978
7.
LightRW, MacgregorMI, LuchsingerPC. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med1972; 77: 507–13.
8.
HeffnerJE, BrownLK, BarbieriCA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest1997; 111: 970–80.
9.
Romero-CandieraS, HernándezL, Romero-BrufaoS. Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions?Chest2002; 122: 1524–9.
10.
Romero-CandieraS, FernándezC, MartinC. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med2001; 110: 681–6.
11.
PorcellJM, AlvaresM, SaludAShould a cytologic study be ordered in transudative pleural effusions?Chest1999; 116: 1836–7.
12.
GarciaL, DucatmanBS, WangHH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol1994; 7: 665–8.
13.
TomlinsonJR. Invasive procedures in the diagnosis of pleural disease. Semin Respir Med1987; 9: 30–60.
14.
BlancFX, AtassiK, BignonJ. Diagnostic value of medical thoracoscopy in pleural disease: a 6-year retrospective study. Chest2002; 121: 1677–83.
15.
BoutinC, ReyF. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer1993; 72: 389–93.
16.
HansenM, FaurschouP, ClementsenP. Medical thoracoscopy, results and complications in 146 patients: a retrospective study. Respir Med1998; 92: 228–32.
17.
LoddenkemperR, MathurPN, LeeP. History and clinical use of thoracoscopy/pleuroscopy in respiratory medicine. Breathe2011; 8: 145–55. http://dx.doi.org/10.1183/20734735.011711
18.
RahmanNM, AliNJ, BrownG. Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010. Thorax2010; 65: ii54–ii60. http://dx.doi.org/10.1136/thx.2010.137018
19.
Van MeterMEM, McKeeKY, KohlwesRJ. Efficacy and safety of tunnelled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med2011; 26: 70–6. http://dx.doi.org/10.1007/s11606-010-1472-0
20.
TremblayA, MichaudG. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest2006; 129:362–8.
21.
TremblayA, MasonC, MichaudG. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J2007; 30: 759–62.
22.
DaviesHE, MishraEK, KahanBC. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA2012; 307: 2383–9. http://dx.doi.org/10.1001/jama.2012.5535
RahmanNM, MaskellNA, WestA. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med2011; 365: 518–26. http://dx.doi.org/10.1056/NEJMoa1012740
